TrialPancreas2020

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial.

Teresa Macarulla Mercadé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.